Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial

OBJECTIVE: Continuous intraperitoneal insulin infusion (CIPII) with an implantable pump has been available for the past 25 years. CIPII, with its specific pharmacodynamic properties, may be a viable treatment alternative to improve glycemic control in patients with type 1 diabetes for whom other the...

Descripción completa

Detalles Bibliográficos
Autores principales: Logtenberg, Susan J., Kleefstra, Nanne, Houweling, Sebastiaan T., Groenier, Klaas H., Gans, Reinold O., van Ballegooie, Evert, Bilo, Henk J.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713651/
https://www.ncbi.nlm.nih.gov/pubmed/19429874
http://dx.doi.org/10.2337/dc08-2340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713651/
https://www.ncbi.nlm.nih.gov/pubmed/19429874
http://dx.doi.org/10.2337/dc08-2340

Ejemplares similares